Vascular Diseases and Therapeutics

Wilbert S. Aronow MD

Wilbert S. Aronow MD is Professor of Medicine at New York Medical College/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 14 books and is author or co-author of 1,521 papers, 399 commentaries or Letters to the Editor, and 1,047 abstracts and is presenter or co-presenter of 1,410 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the ASPC, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 144 editorial boards of medical journals, editor-in-chief of 2 journals, co-editor of 2 journals, deputy editor of 1 journal, executive editor of 2 journals, associate editor for 9 journals, and guest editor for 7 other medical journals.

He has received each year from 2001-2016 an outstanding teacher and researcher award from the medical residents and from 2001-2016 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor’s Research Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, 2013, 2014, and 2015, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012.

He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and is currently a member of the writing group of the 2017ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ ASH/ASPC/NMA/PCNA guidelines for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum.

He was a consultant to the ACP Information and Educational Resource (PIER) on the module of aortic stenosis, a member of the Board of Directors of the ASPC, a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee, and a member of the Scientific Executive Committee of the International Academy of Cardiology. He was a peer reviewer of the 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA/HFSA Guideline for the Management of Heart Failure.

Editor-in-Chief

---

Wilbert S. Aronow MD

Harvard Medical School, USA

Read more

Associate Editors

Editorial Board

In Press

Current Issue

Volume 7, Issue 1

Archive

External Databases & Indexes

• WorldCat
• Crossref
• Road
• Google scholar
• Pubmed*
• Publons
• Refseek
• Electronic Journals Library (EZB)
• Scientific Indexing Services (SIS)
• SciLit
• CiteFactor
• Directory of Research Journals
• SciCurve Open

All published articles are provided with DOI and are permanently archived at Open Access Text website in PDF and HTML formats.

Submit Manuscript

VDT welcomes direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com alternatively to: editor.vdt@oatext.com

Publication Charges

Vascular Diseases and Therapeutics is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Vascular Diseases and Therapeutics are USD 850.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

• Recover capitalization costs;
• Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
• Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

1. Wire/Bank transfer
2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.